Departamento de Genética, Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Laboratório de Bioinformática - LABINFO, Laboratório Nacional de Computação Científica, LNCC/MCTIC, Getúlio Vargas, Av., 333, Quitandinha, Zip Code: 25651‑075, Petrópolis, Rio de Janeiro, Brazil.
Mol Med. 2022 Dec 12;28(1):153. doi: 10.1186/s10020-022-00583-5.
Multisystem Inflammatory Syndrome in Children (MIS-C) is a life-threatening complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which manifests as a hyper inflammatory process with multiorgan involvement in predominantly healthy children in the weeks following mild or asymptomatic coronavirus disease 2019 (COVID-19). However, host monogenic predisposing factors to MIS-C remain elusive.
Herein, we used whole exome sequencing (WES) on 16 MIS-C Brazilian patients to identify single nucleotide/InDels variants as predisposition factors associated with MIS-C.
We identified ten very rare variants in eight genes (FREM1, MPO, POLG, C6, C9, ABCA4, ABCC6, and BSCL2) as the most promising candidates to be related to a higher risk of MIS-C development. These variants may propitiate a less effective immune response to infection or trigger the inflammatory response or yet a delayed hyperimmune response to SARS-CoV-2. Protein-Protein Interactions (PPIs) among the products of the mutated genes revealed an integrated network, enriched for immune and inflammatory response mechanisms with some of the direct partners representing gene products previously associated with MIS-C and Kawasaki disease (KD). In addition, the PPIs direct partners are also enriched for COVID-19-related gene sets. HLA alleles prediction from WES data allowed the identification of at least one risk allele in 100% of the MIS-C patients.
This study is the first to explore host MIS-C-associated variants in a Latin American admixed population. Besides expanding the spectrum of MIS-C-associated variants, our findings highlight the relevance of using WES for characterising the genetic interindividual variability associated with COVID-19 complications and ratify the presence of overlapping/convergent mechanisms among MIS-C, KD and COVID-19, crucial for future therapeutic management.
儿童多系统炎症综合征(MIS-C)是严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的一种危及生命的并发症,主要发生在轻度或无症状 2019 年冠状病毒病(COVID-19)后数周内的健康儿童中,表现为多器官受累的过度炎症过程。然而,MIS-C 的宿主单基因易感性因素仍不清楚。
本研究采用 16 例巴西 MIS-C 患者的外显子组测序(WES),以鉴定与 MIS-C 相关的单核苷酸/InDels 变体作为易感性因素。
我们在 8 个基因(FREM1、MPO、POLG、C6、C9、ABCA4、ABCC6 和 BSCL2)中发现了 10 个非常罕见的变体,这些变体可能与 MIS-C 发病风险增加有关。这些变体可能导致对感染的免疫反应不那么有效,或触发炎症反应,或对 SARS-CoV-2 的迟发性超免疫反应。突变基因产物之间的蛋白-蛋白相互作用(PPIs)揭示了一个集成网络,富含免疫和炎症反应机制,其中一些直接伙伴代表与 MIS-C 和川崎病(KD)相关的基因产物。此外,PPIs 的直接伙伴也富含与 COVID-19 相关的基因集。从 WES 数据预测 HLA 等位基因,在 100%的 MIS-C 患者中至少鉴定出一个风险等位基因。
本研究首次在拉丁美洲混合人群中探索与宿主 MIS-C 相关的变异。除了扩大与 MIS-C 相关的变异谱外,我们的研究结果还强调了使用 WES 来描述与 COVID-19 并发症相关的个体遗传变异性的重要性,并证实了 MIS-C、KD 和 COVID-19 之间存在重叠/趋同机制,这对未来的治疗管理至关重要。